LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

Biotechnology

Healthcare
$40.06 -1.30%

-$0.39 today

Market cap
$1.30B
Beta
0.71
P/E (TTM)
-21.4
EPS (TTM)
-$1.39
52W Low $13.36High $33.47

Volume 0.36M

Average 0.23M

LBRX Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

No reported Net Margin figures are available to summarize.

Net Margin history

Percent of revenue · from the income statement

No Net Margin data reported for this period type.

Net Margin vs competitors

How LBRX compares with its peers on the latest reported figures

LBRX Competitors Peer median
Net Margin for LBRX and competitors
Company Period LTM level YoY 3-year change
ACADACADIA Pharmaceuticals Inc.LTM Sep 202630.1% +5.2 pp+78.2 pp
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026-536.4% ——
DNLIDenali Therapeutics Inc.LTM Jun 2026-14191.2% ——
LBRXLB Pharmaceuticals Inc Common StockFY2025— ——
DFTXDefinium Therapeutics, Inc.FY2025— ——
GHRSGH Research PLCFY2025— ——
ANROAlto Neuroscience, Inc.FY2025— ——
SPTXSeaport Therapeutics, Inc. Common Stock—— ——
MPLTMapLight Therapeutics, Inc.FY2025— ——
NERVMinerva Neurosciences, Inc.FY2025— ——
NMRANeumora Therapeutics, Inc. Common StockFY2025— ——
Peer median (excluding LBRX) -536.4%+5.2 pp+78.2 pp

Competitors are the stored peer set for LBRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue0000
Gross Profit0000
Gross Margin————
Research & Development1.35M7.85M51.17M16.74M
Selling, General & Admin1.46M3.53M13.66M13.66M
Operating Expenses2.81M11.38M64.83M30.4M
Depreciation & Amortization2K4K91K321K
EBITDA(12.19M)(1.45M)(63.01M)(24.88M)
EBITDA Margin————
Operating Income(2.81M)(11.38M)(64.83M)(30.4M)
Operating Margin————
Interest Income73K811K1.72M3.92M
Interest Expense2.15M4.83M00
Other Income / Expenses(11.54M)5.1M1.73M5.2M
Income Before Tax(14.35M)(6.27M)(63.1M)(25.2M)
Pre-Tax Margin————
Income Tax Expense1K1K1K1K
Net Income(14.35M)(6.28M)(63.1M)(25.21M)
Net Margin————
EPS (Basic)(4.05)(1.77)(17.83)(1.00)
EPS (Diluted)(4.05)(1.77)(17.83)(1.00)
Weighted Avg Shares3.54M3.54M3.54M25.3M
Weighted Avg Shares (Diluted)3.54M3.54M3.54M25.3M

LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

Intrinsic Alpha fair value

Locked

Current Price

$40.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.